, welcomed Mr Buchi's appointment. "Kevin's impressive track record in the international biotechnology and pharmaceutical industry over 30 years provides Benitec with significant additional business development strength, and importantly, networking capacity in the United States
. The Directors and Management look forward to working closely with Kevin to achieve the Company's aims through industry partnerships. We see this as a validation of Benitec's corporate strategy over the past few years."
Mr. Buchi commented, "I continue to be impressed with Benitec's programs and progress. The expected entry of the Company's Hepatitis C therapy into the clinic later this year is validation of that progress. I believe that Benitec Biopharma's technology and programs have the potential to bring about a revolution in treatment of many diseases and conditions through the power of DNA-directed RNA interference. I look forward to working with the Company to help advance its exciting programs and vision."
For more information please contact:
Dr. Peter French | Chief Executive Officer
Phone: +61 (02) 9555 6986 | email@example.com | www.benitec.com
About Benitec Biopharma Limited:
Benitec Biopharma Limited is an ASX-listed biotechnology company (ASX Code: BLT) based in Sydney, Australia. The company has a pipeline of in-house and partnered therapeutic programs based on its patented gene-silencing technology, ddRNAi. Benitec is developing treatments for chronic and life-threatening human conditions such as Hepatitis C, Hepatitis B, wet age-related macular degeneration, cancer-associated pain, drug r
Page: 1 2 3 Related biology technology :1
|SOURCE Benitec Biopharma Limited|
Copyright©2012 PR Newswire.
All rights reserved
. National Honey Board Seeks Board Member Nominees: Appointments to be Made by United States Secretary of Agriculture2
. TaxOps Announces Partner Appointment to Prominent International Position with Fortune 100 Company3
. Store-A-Tooth™ Stem Cell Banking Announces Appointment of Dedicated Sales Representative in New England4
. Aratana Therapeutics Adds Product Manufacturing Expertise with the Appointment of Two Senior Executives5
. PharmaDirections Announces Appointment of Dr. Bruce Rehlaender as Principal, Formulation Development6
. Mobility and Big Data Analytics Provider NuWare Announces the Appointment of Rohit Shyam as Chief Strategy & Marketing Officer7
. Store-A-Tooth™ Dental Stem Cell Banking Announces Appointment of Dedicated Representative in South Florida8
. Sequenom Announces Leadership Appointments9
. T1D Exchange Announces Appointment of Dana Ball as Chief Executive Officer10
. Gallus BioPharmaceuticals Announces Appointment of Senior Baxter Executive as Chief Commercial Officer11
. Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012